Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss
Science Advances · 20.02.2026 · 12 (8)
DOI: 10.1126/sciadv.adv5457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.02.2026. Verfasst von Sabrina Y Camp und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Carcinoma, Renal Cell, Interferons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Parker Institute for Cancer Immunotherapy.
Abstract (Originalsprache)
Transcriptional programs in renal cell carcinoma (RCC) have been linked to tumor heterogeneity and clinical outcomes, but analogous efforts to define chromatin programs shaping disease biology have been limited. Here, we generated single-cell ATAC-seq profiles from patients with RCC and integrated them with three previously published datasets to identify chromatin programs in tumor cells. We identified an interferon response program enriched in BAP1 -mutant tumors, and, in bulk ATAC-seq cohorts with linked clinical data, this program was associated with poor prognosis. Mechanistic analyses in isogenic models suggested that BAP1 loss induces a tumor-intrinsic interferon response, with dysregulated endogenous retroviruses as a potential upstream trigger. We further characterized the BAP1 mutation–associated tumor microenvironment across single-cell, bulk, and multiplex immunofluorescence data, identifying features of both inflammation and immune evasion. Together, our findings nominate tumor-intrinsic interferon signaling as a candidate driver of BAP1 -associated aggressiveness in RCC and highlight immune evasion pathways as potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
- Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
- Harvard Graduate Program in Biophysics, Boston, MA 02115, USA.
- Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, CA 92093, USA.
- Systems, Synthetic, and Quantitative Biology Graduate Program, Harvard University, Cambridge, MA 02138.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
ORCID-Profile: Sabrina Y Camp, Michael S Cuoco, Amanda E Garza, Sherin Xirenayi, Ziad Bakouny, Eddy Saad, Erica Pimenta, Kevin Meli, Chris Labaki, Breanna M Titchen, Jack Horst, Aaron R Thorner, Sébastien Vigneau, Hannah Lachmayr, Pengsheng Chen, Haiteng Deng, Toni K Choueiri, Kevin Bi, Eliezer M Van Allen
Förderung
- NCI NIH HHS
- National Institutes of Health
- Parker Institute for Cancer Immunotherapy
- National Science Foundation Graduate Research Fellowship Program
- Fujifilm Corporation
- The Ambrose Monell Foundation
Zitieren
APA
Camp, S. Y., He, M. X., Cuoco, M. S., Garza, A. E., Xirenayi, S., Bakouny, Z., Saad, E., El Masri, J., Pimenta, E., Meli, K., Labaki, C., Titchen, B. M., Kang, Y. J., Horst, J., Trowbridge, R., Shannon, E., Helvie, K., Thorner, A. R., Vigneau, S., …, & Van Allen, E. M. (2026). Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss. Science Advances, 12(8). https://doi.org/10.1126/sciadv.adv5457
Vancouver
Camp SY, He MX, Cuoco MS, Garza AE, Xirenayi S, Bakouny Z, et al. Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss. Science Advances. 2026;12(8). doi:10.1126/sciadv.adv5457
BibTeX
@article{Camp2026,
author = {Camp, Sabrina Y and He, Meng Xiao and Cuoco, Michael S and Garza, Amanda E and Xirenayi, Sherin and Bakouny, Ziad and Saad, Eddy and El Masri, Jad and Pimenta, Erica and Meli, Kevin and Labaki, Chris and Titchen, Breanna M and Kang, Yun Jee and Horst, Jack and Trowbridge, Rachel and Shannon, Erin and Helvie, Karla and Thorner, Aaron R and Vigneau, Sébastien and Mayorga, Angie and Kodali, Jahnavi and Lachmayr, Hannah and Bemus, Meredith and Chen, Pengsheng and Deng, Haiteng and Park, Jihye and Choueiri, Toni K and Bi, Kevin and Van Allen, Eliezer M},
title = {Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {8},
doi = {10.1126/sciadv.adv5457}
}
EUVIMED